- March 23, 2015
Zirconia dioxide has a long history of use in orthopedic and dental applications. Zirconium (Zr) is a metal; however, through a chemical reaction with oxygen, zirconium is converted to zirconia or zirconium dioxide (ZR02). Currently, there are several manufacturers of zirconia dioxide dental implants.
Z-Systems, a Swiss-manufactured single-piece dental implant, was FDA approved more than four years ago for use in tooth-re- placement therapy. Developed in 2001 by Dr. Ulrich Volz, in collabo- ration with Metoxit, a world leader in the production of ceramic ma- terial, the new implants offered a predictable way to produce strong, dimensionally stable, metal-free implants using the isostatic process.
A key element of success in the process is the quality of the raw materials and the technology of the production. Not all zirconia is created equal. Currently, worldwide it is estimated that 3 percent of patients may be sensitive to titanium. In addition, the systemic toxicity associated with titanium nanotechnology is still unknown.  However, it does appear there is peripheral organ accumulation of metal ions in certain clinical situations. [9-10]
How this affects overall health is still unknown. With increasing frequency, patients are requesting metal-free biologic implants and restorative solutions. Many holistic and esthetically oriented doctors and patients are looking for a metal-free esthetic option in tooth replacement therapy.
Zirconia biocompatibility has been successfully documented in animal studies and human studies. These studies have found zirconia to be biologically compatible with osseointegration. Specifically, they have reported cellular responses similar to titanium, similar bone-to-implant contact, similar healing times, similar biomechanical strength and similar soft-tissue biologic width, and similar removal torque values. [11-25]
Additionally, several studies have shown less inflammatory infiltrate at the implant abutment junction and less bacterial colonization in this region, which may have clinical significance regarding short and long-term biofilm accumulation and susceptibility. [26-30]
The only human clinical retrospective study to date in the literature on human success rates of zirconia reported a 92 percent success for smooth surface zirconia and 97 percent for rough surface zirconia over five years and 831 subjects. 
The Z-look Evo is a single-stage threaded implant with a prep-able abutment. It is imperative to use the 49 micron zirconia prep bur for reduction to reduce microcrack propagation. Preparation can be completed at placement. There is no risk of heating of the implant body because of the low thermal conductivity of the material.  The apical thread pattern is self-tapping. The current surface is sandblasted to improve surface characteristics. However, a new dual-processed sand-blasted and laser-etched surface is now available.
The single-stage design eliminates the effects of the microgap and micromotion on the crestal interface of bone and soft tissue [Fig. 1]. The current diameters range from 3.3 to 5.5 mm and from 8.5 to 15 mm length [Fig 2].
Diagnosis and Treatment Planning
The author has been selectively placing zirconium Implants during the last three years. The following considerations should be strictly adhered to when considering diagnosis and placement. Consider guided surgery for optimal alignment from a top (crown)-down approach. The abutment can be prepped up to 20 degrees. Any misalignment beyond 20
degrees will cause restorative complications. Snap Caps and Analogs are available for impressions and lab processes [Figs. 3-5].
Only place the implant in healthy patients with no systemic and local risk factors such as smoking, diabetes, poor bone quality and metabolic deficiencies. Type 1-2 host bone is ideal for successful integration.
Zirconia tends to lag four weeks behind in cellular biologic fixation, according to
animal studies. In sites with native bone, I will allow implants to remain undisturbed
for four months on the lower and six months on the upper.
Limiting any micromotion at the bone to implant interface is crucial. An essex appliance is recommended during healing. Because grafted sites still contain areas of devitalized bone, longer healing times are important.
The following healing times are suggested for grafted sites. Allow grafted bone in extraction sockets on the maxillary arch to heal a minimum of six months, even when using bioactive modifiers; sinus grafts a minimum of eight months; and lateral ridge augmentations on the upper and lower arch eight months prior to implant placement.
Consider undersizing the osteotomy to develop optimal primary stability. Progressive long-term loading in provisionals is highly recommended to begin the accommodative physiologic bone response at the cellular level. There is no replacement for experience, and the success of zirconia implant therapy is directly related to the operators’ surgical and prosthetic skills and experience.
The primary means of surface modification to enhance surface microtexture on zirconia include acid etching, laser etching and sandblasting. These processes will enhance the hosts’ cellular response and secondary fixation. However, remember zirconia’s secondary fixation occurs about four weeks slower than titanium. Therefore, not only is protected healing required, but longer healing times are beneficial. Crestal biologic bone response will always include accommodative bone resorption to the first thread. As a result of the implant design, 2 mm of bone loss will occur upon placement to provide room for biologic width [Fig, 6].
A two-piece design with a medialized offset will eventually provide the opportunity to preserve crestal bone, while providing optimal restorative interface options. Immediate loading and implants placed into extraction sockets is not recommended at this time, as there is not enough clinical information or literature to support this approach.
Soft-tissue response is remarkable with crestal creeping soft-tissue attachment over time [Fig. 7]. It has been shown fibroblasts migrate extremely well on zirconia sur-faces. [35-36] As well, biofilm development is retarding as result of the surface biodynamics. 
To date, I have not reported any biomechanical failures including fracture, nor have any been reported in the literature.
It appears from the literature that at the 12-week point in animal studies, the bone to implant contact and removal torque analysis for zirconium and titanium is the same [Fig 8].
Stress distribution for zirconia and titanium is the same. The esthetic benefits of zirconia prevent the grey show-through associated with many titanium implants, particularly in the thin biotypes [Fig. 9].
A 55-year-old man with remarkable health had lost #8 five years prior. The area was never grafted. Zirconia success is optimal in host bone [Fig. 10]. A 4.0 by 13 Z–Look was secured under 50 ncm of torque [Fig. 11]. An essex appliance was placed for the du- ration of the four-month healing interval [Fig. 12]. A four-week post-op revealed dynamic soft tissue health and composition.
A provisional was placed at four months and progressively loaded over the next two months [Fig. 13].
A final all-zirconium crown was placed at six months. X-ray and cone beam at the one-year mark reveal crestal bone loss to the first thread. However, they also show excellent tissue stability and esthetics [Figs. 14-17].
Fig. 1: The single-stage design eliminates the effects of the microgap and micromotion on the crestal interface of bone and soft tissue. (A) – a uniform Cad-Cam abutment for all standard implants without insertion hexagon; optimized by large surface transmission of force on two parallel surfaces; retention groove for holding tools and accessories securely; angulation and individualization by simple grinding. (B) Optimized possibilities of indication thanks to new implant sizes with reduced shoulder width; Perfiect individualo aesthetics by grindable preparation border (C) Tapering thread with widened core diameter in the upper part of the thread guarantees optimum mechanical strength and better primary stability. (D) Improved self-tapping thread; newly designed bone chip reservoir.
Fig. 2: The current diameters range from 3.3 to 5.5 mm and from 8.5 to 15 mm length.
Figs. 3-5: Snap Caps and Analogs are available for impressions and lab processes.
Fig. 6: As a result of the implant design, 2 mm of bone loss will occur upon placement to provide room for biologic width.
Fig. 7: Soft-tissue response is remarkable with crestal creeping soft-tissue attachment over time.
Fig. 8: The bone to implant contact and removal torque analysis for zirconium and titanium is the same.
Fig. 9: The esthetic benefits of zirconia prevent the grey show-through associated with many titanium implants, particularly in the thin biotypes.
Fig. 10: A 55-year-old man with remarkable health had lost #8 five years prior. The area was never grafted. Zirconia success is optimal in host bone.
Fig. 11: A 4.0 by 13 Z–Look was secured under 50 ncm of torque.
Fig. 12: An essex appliance was placed for the duration of the four-month healing interval.
Fig. 13: A provisional was placed at four months and progressively loaded during the next two months.
Figs. 14-15: A final all-zirconium crown was placed at six months.
Figs. 16-17: X-ray and cone beam at one-year mark reveal crestal bone loss to the first thread; however, they also show excellent tissue stability and esthetics.
1. Stejskal J, Stejskal VD. The role of metals in autoimmunity and the link to nueroendocrinology. Neuroendo- crinology lett 1999;20:351-364.
2. Valentine-Thon E, Schiwara HW, Validity of MELISA for metal sensitivity testing. Neuroend lett.2003;24:57- 64.
3. Hypersensitivity To Titanium:Clinical and Laboratory Evidence. Muller KE, Valentine-Thon E.Nueroendocrinol letter. 2006;27 suppl 1:31-35.
4. Elizabeth Valentine-Thon1, PhD; Kurt Müller2, MD; Gianpaolo Guzzi3, DDS; Sybille Kreisel4, MD; Peter Ohnsorge5, MD & Martin Sandkamp1, MD Neuroendocrinol Lett 2006; 27(Suppl 1):17–24. 5. Stejskal V. Human hapten-specific lymphocytes: biomarkers of allergy in man. Drug Inform J. 1997; 4: 379– 82.
6. Sicilia A, Cuesta S, Coma G, Arregui I, Guisasola C, Ruiz E, Maestro A. Clin Oral Implants Res. 2008 Aug;19(8):823-35.
7. Egusa H, Ko N, Shimazu T, Yatani HJ Prosthet Dent. 2008 Nov;100(5):344-7.
8. Wennberg Ann et al, Inter J Oral maxifac implants 2011;26:1161-1166.
9. Bianco PD, et al, J of Biomedical Research,1996:31:227-234.
10. Weingart et al, Inter nat Journal Maxofacial Surgery, 1994:23:450-452.
11. Shin D, Blanchard SB, Ito M, Chu TM Clin Oral Implants Res. 2010 Sep 10.
12. Shin D, Blanchard SB, Ito M, Chu T-MG. Peripheral quantitative computer tomographic, histomorphometric, and removal torque analyses of two different non-coated implants in a rabbit model. Clin. Oral Impl. Res. xx, 2010. 13. 2008 Depprich et al Head Face Med. 2008; 4:30.
14. Stadlinger B, Hennig M, Eckelt U, Kuhlisch E, Mai R. Department of Oral & Maxillofacial Surgery, Faculty of Medicine, University of Technology Dresden, Germany.
15. Koch FP, Weng D, Krämer S, Biesterfeld S, Jahn-Eimermacher A, Wagner W JOMI Vol 21, Issue 3, p.350- 356, March 2010.
16. Kohal RJ, Weng D, Bachle M, Strub G. Loaded custom Zirc and titanium implants show similar osseointegration. An animal experiment. J Perio . 2004. 75: 1262-1268
17. Albrektsson et al, Interface analysis of ti and zir implants. Biomaterials 1985:6:97-101.
18. Akagawa Y, et al. Interface histology of unloaded and early loaded partially stabilized zirconia. J Prosth Dent 1993;69:599-604.
19. Akagawa Y Et al, Comparison between freestanding and tooth connected partiallystabilized zirconia implants after 2 years in function in monkeys. Clinical and Histology. J Prosth Dent.1998;80:551-558.
20. Ichikawa Y et al, Tissue Compatibility and stability of a new zirconium ceramic. In vivo. J Prosth Dent 1992: 68:322-326.
21. Kohal et al, 3 dimensional computerized stress analysis of ti and zirc implants. Int J Prosth 2002:15:189-194. 22. Sennerby et al. Bone tissue response to zirconia implants: A histomorphometric and removal torque study. Clin Implants Dent Res 2005:s13-20.
23. Andreiotelli M, kohal RJ. Survival rate and fracture resistance of zirconium Dioxide implants after exposure to the artificial mouth: An in vitro study. Freidburg, 2006. Reprinted in 2008.
24. Caglar A, Bal BT, Aydin C, Yilmaz H, Ozkan S Evaluation of stresses occurring on three different zirconia dental implants: three-dimensional finite element analysis Int J Oral Maxillofac Surg. 2010 Jun;39(6):585-92. 25. M.Nevins,M.Nevins,M.Camela,P. Schupback,D.Kim. Pilot Clinical and Histologic Evaluation of a 2 piece zirconium Implant. Int Journal of Perio and Rest. Dent.2011:31:157-163.
26. Degidi et al. Inflammatoy infiltrate,microvessel density, nitric oxide expression,vascular endothelial growth factor expression, and profilerative activity in peri-implant soft tissues around ti and zirc oxide healing Caps. J PERIO 2006;77:73-78.
27. Rimondini et al. Bacterial Colonization of ceramic surfaces: An In Vitro Study and In Vivo Study. Int J Oral and Max Implants 2002;17;793-798.
28. Scarano A, Piatelli M et al. Bacterial Adhesion on Pure Zirc and Ti discs. An in vivo human study. J Perio 2004; 75:292-296.
29. Linkevicious T Et al. Influence of abutment material on stability of periimplant tissues. A systemic Review. Int J Oral Max Implants 2008;23:449-456.
30. M. Nevins, M. Nevins, M. Camela, P. Schupback, D.Kim. Pilot Clinical and Histologic Evaluation of a 2-piece zirconium Implant. Int Journal of Perio and Rest. Dent.2011:31:157-163.
31. Oliva J, Oliva X, Oliva JD Five-year success rate of 831 consecutively placed Zirconia dental implants in humans: a comparison of three different rough surfacesInt J Oral Maxillofac Implants. 2010 Jan-Feb;25(1):95-103.
32. Caglar, A et al, Int J Oral Maxillofac Implants 2011;26; 961-969.
33. Marco Degidi,*† Luciano Artese,‡ Antonio Scarano,† Vittoria Perrotti,† Peter Gehrke,§ and Adriano Piattelli:Journal of Perio January 2006, Vol. 77, No. 1, p. 73-80.
34. Antonio Scarano, Maurizio Piattelli , Sergio Caputi , Gian Antonio Favero , Dr. Adriano Piattelli Journal of Periodontology Feb 2004, Vol. 75, No. 2, Pages 292-296: 292-296.